Related Experiment Videos
Labetalol in resistant hypertension
Acta Medica Scandinavica. Supplementum
|January 1, 1982
Summary
Labetalol effectively lowers blood pressure in patients with resistant hypertension. This medication may be a valuable addition to existing therapies, particularly when combined with diuretics, offering significant BP reduction.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Resistant hypertension poses a significant challenge in cardiovascular disease management.
- Existing antihypertensive drug combinations may not always achieve target blood pressure goals.
Purpose of the Study:
- To evaluate the efficacy of labetalol as an add-on therapy for patients with resistant hypertension.
- To assess the impact of labetalol on blood pressure reduction and identify potential side effects.
Main Methods:
- A cohort of 12 patients with resistant hypertension received labetalol in addition to their existing medications.
- Patients were followed for an average of 3.5 years, with blood pressure monitored under various conditions (supine, standing, post-exercise).
Main Results:
- Significant reductions in mean supine blood pressure (202/123 to 163/103 mm Hg) and standing blood pressure (193/127 to 144/100 mm Hg) were observed.
- Post-exercise blood pressure averaged 134/93 mm Hg.
- The primary side effect was postural hypotension during exercise, leading to labetalol withdrawal in two patients.
Conclusions:
- Labetalol can achieve satisfactory blood pressure reduction in patients with severe, drug-resistant hypertension.
- Combining labetalol with a potent diuretic may enhance its effectiveness in managing resistant hypertension.